UK reg­u­la­tor says trial of HCQ for Covid can resume

Hindustan Times (Jalandhar) - - WORLD - HT Cor­re­spon­dent and Agen­cies let­ters@hin­dus­tan­

LON­DON:A global trial de­signed to find out whether the an­ti­malar­ial drug hy­drox­y­chloro­quine (HCQ) can pre­vent in­fec­tion with Covid-19 will restart af­ter get­ting ap­proval from the UK medicines agency. The Medicines and Health­care Prod­ucts Reg­u­la­tory Agency’s de­ci­sion on the trial comes af­ter the drug was found in an­other UK trial to have no ben­e­fit for pa­tients al­ready in­fected with Covid-19.


UK Prime Min­is­ter Boris John­son on Tues­day an­nounced a £5 bil­lion eco­nomic pack­age to re­cover from what he called the “dis­as­ter” of the cor­navirus pan­demic, as the east Mid­lands town of Le­ices­ter with a large pop­u­la­tion of In­dian ori­gin went into the UK’s first lo­cal lock­down.

Harp­ing on the mantra of “build, build, build”, John­son drew com­par­isons with for­mer US Pres­i­dent Franklin Roosvelt’s “New Deal” that took the coun­try out of de­pres­sion in the 1930s.

Eng­land is due to ease lock­down re­stric­tions on Satur­day, but Le­ices­ter will be ex­cluded due to a spike in in­fec­tions, par­tic­u­larly among young peo­ple. The in­fec­tions are par­tic­u­larly high in ar­eas of pre-ex­ist­ing eco­nomic de­pri­va­tion, such as Ev­ing­ton.

John­son said, “Too many parts of this coun­try have felt left be­hind, ne­glected, unloved, as though some­one had taken a strate­gic de­ci­sion that their fate did not mat­ter as much as the me­trop­o­lis.”

The eco­nomic pack­age in­cludes build­ing new homes, schools, more fund­ing for the Na­tional Health Ser­vice, tack­ling skills cri­sis and bridg­ing gaps in con­nec­tiv­ity, pro­duc­tiv­ity and op­por­tu­nity.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.